CorVel(US:CRVL)2025-05-21 23:30Financial Performance - Revenues for Q4 FY 2025 were $232 million, a 12% increase from $207 million in Q4 FY 2024[6] - Earnings per share for Q4 FY 2025 were $0.51, up 38% from $0.37 in the same quarter of the prior year[6] - Fiscal year revenues reached $896 million, a 12.7% increase from $795 million in FY 2024[1] - Net income for FY 2025 was $95.2 million, compared to $76.3 million in FY 2024[8] Profitability and Margins - Gross profit for Q4 FY 2025 increased 34% to $58 million, with a gross margin of 25%[6] Cash and Assets - The company exited the quarter with $171 million in cash and cash equivalents, with no borrowings[6] - Total assets as of March 31, 2025, were $546 million, up from $455 million in the previous year[9] Strategic Initiatives - CorVel's AI integration is enhancing communication platforms and medical billing practices, improving efficiency and reducing costs[3] - The health market saw the successful launch of CERIS's first customer and a second partnership agreement, aligning with the company's long-term strategy[4] Shareholder Actions - The company repurchased $9 million of common stock during the quarter[6]